Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BYBiomedicines

Evaluation of FGD3 Expression in Advanced Prostate Cancer

4 affiliations
  1. 1Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, , 85-094 Bydgoszcz, Poland
  2. 2Department of Dermatology and Venerology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, , 85-094 Bydgoszcz, Poland;
  3. 3Department of Urology and Andrology, Ludwik Rydygier Collegium Medicum, , 85-094 Bydgoszcz, Poland;
  4. 4Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, , 85-094 Bydgoszcz, Poland;

Related

  1. A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer.
    S. Sridhar, K. Mohan, S. Kizhake +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Perioperative apalutamide in high-risk localized or locally advanced prostate cancer: Is PROTEUS trial practice changing?
    Muhammed Huzaifa
    Indian journal of urology : IJU : journal of the Urological Society of IndiaPeer-reviewedCC BY-NC-SAFull textGeneral medicineEurope PMC
  3. Balanced double aortic arch with late-onset symptoms detected on 18F-FDG PET/CT in an octogenarian with advanced prostate cancer : A case report
    Qiang Wei, Panhui Liu, Yinghua Wu
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Dual inhibition of p38α MAPK and Casein kinase δ/ϵ as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer
    S. Chakravarti, S. Mazumder, F. Hemmati +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. Oral Targeted Therapies and Clinician Comanagement Among Men With Advanced Prostate Cancer
    Arnav Srivastava, Anqi Sun, Megan E. V. Caram +2
    JAMA Network OpenPeer-reviewedCC BY 4.0General medicineCrossref
BibTeX
@article{malinowski2026evaluation,
  title = {{Evaluation of FGD3 Expression in Advanced Prostate Cancer}},
  author = {Bartosz Malinowski and Paulina Antosik and Layla Settaf-Cherif and Dariusz Grzanka and Michał Wiciński},
  journal = {Biomedicines},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13702019},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Evaluation of FGD3 Expression in Advanced Prostate Cancer
AU  - Bartosz Malinowski
AU  - Paulina Antosik
AU  - Layla Settaf-Cherif
AU  - Dariusz Grzanka
AU  - Michał Wiciński
PY  - 2026
DA  - 2026/10/01
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13702019
SN  - 2227-9059
ER  -